COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022

Mostrar otras versiones (1)

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? COVID-19 vaccines are important tools to protect populations from severe disease and death. WHAT IS ADDED BY THIS REPORT? Among persons aged ≥60 years in Hong Kong, 49%, had received ≥2 doses of a COVID-19 vaccine, and vaccination coverage declined with age. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Dallas J., Hakim, Avi J., Leung, Gabriel M., Xu, Wenbo, Schluter, W. William, Novak, Ryan T., Marston, Barbara, Hersh, Bradley S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008266/
https://www.ncbi.nlm.nih.gov/pubmed/35433091
http://dx.doi.org/10.46234/ccdcw2022.071
_version_ 1784687012790403072
author Smith, Dallas J.
Hakim, Avi J.
Leung, Gabriel M.
Xu, Wenbo
Schluter, W. William
Novak, Ryan T.
Marston, Barbara
Hersh, Bradley S.
author_facet Smith, Dallas J.
Hakim, Avi J.
Leung, Gabriel M.
Xu, Wenbo
Schluter, W. William
Novak, Ryan T.
Marston, Barbara
Hersh, Bradley S.
author_sort Smith, Dallas J.
collection PubMed
description WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? COVID-19 vaccines are important tools to protect populations from severe disease and death. WHAT IS ADDED BY THIS REPORT? Among persons aged ≥60 years in Hong Kong, 49%, had received ≥2 doses of a COVID-19 vaccine, and vaccination coverage declined with age. During January–March 2022, reported COVID-19–associated deaths rose rapidly in Hong Kong. Among these deaths, 96% occurred in persons aged ≥60 years; within this age group, the risk for death was 20 times lower among those who were fully vaccinated compared with those who were unvaccinated. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? Efforts to identify and address gaps in age-specific vaccination coverage can help prevent high mortality from COVID-19, especially in older adults.
format Online
Article
Text
id pubmed-9008266
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-90082662022-04-15 COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022 Smith, Dallas J. Hakim, Avi J. Leung, Gabriel M. Xu, Wenbo Schluter, W. William Novak, Ryan T. Marston, Barbara Hersh, Bradley S. China CDC Wkly Preplanned Studies WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? COVID-19 vaccines are important tools to protect populations from severe disease and death. WHAT IS ADDED BY THIS REPORT? Among persons aged ≥60 years in Hong Kong, 49%, had received ≥2 doses of a COVID-19 vaccine, and vaccination coverage declined with age. During January–March 2022, reported COVID-19–associated deaths rose rapidly in Hong Kong. Among these deaths, 96% occurred in persons aged ≥60 years; within this age group, the risk for death was 20 times lower among those who were fully vaccinated compared with those who were unvaccinated. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? Efforts to identify and address gaps in age-specific vaccination coverage can help prevent high mortality from COVID-19, especially in older adults. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022-04-08 /pmc/articles/PMC9008266/ /pubmed/35433091 http://dx.doi.org/10.46234/ccdcw2022.071 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Preplanned Studies
Smith, Dallas J.
Hakim, Avi J.
Leung, Gabriel M.
Xu, Wenbo
Schluter, W. William
Novak, Ryan T.
Marston, Barbara
Hersh, Bradley S.
COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022
title COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022
title_full COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022
title_fullStr COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022
title_full_unstemmed COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022
title_short COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022
title_sort covid-19 mortality and vaccine coverage — hong kong special administrative region, china, january 6, 2022–march 21, 2022
topic Preplanned Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008266/
https://www.ncbi.nlm.nih.gov/pubmed/35433091
http://dx.doi.org/10.46234/ccdcw2022.071
work_keys_str_mv AT smithdallasj covid19mortalityandvaccinecoveragehongkongspecialadministrativeregionchinajanuary62022march212022
AT hakimavij covid19mortalityandvaccinecoveragehongkongspecialadministrativeregionchinajanuary62022march212022
AT leunggabrielm covid19mortalityandvaccinecoveragehongkongspecialadministrativeregionchinajanuary62022march212022
AT xuwenbo covid19mortalityandvaccinecoveragehongkongspecialadministrativeregionchinajanuary62022march212022
AT schluterwwilliam covid19mortalityandvaccinecoveragehongkongspecialadministrativeregionchinajanuary62022march212022
AT novakryant covid19mortalityandvaccinecoveragehongkongspecialadministrativeregionchinajanuary62022march212022
AT marstonbarbara covid19mortalityandvaccinecoveragehongkongspecialadministrativeregionchinajanuary62022march212022
AT hershbradleys covid19mortalityandvaccinecoveragehongkongspecialadministrativeregionchinajanuary62022march212022

Ejemplares similares